메뉴 건너뛰기
Medicina Clinica
Volumn 127, Issue 18, 2006, Pages 716-
Sustained remission in an adult patient with Langerhans cell histiocytosis following T-cell depleted allogenic cell transplantation [2];Remisión completa continuada en una paciente adulta con histiocitosis de células de Langerhans tras trasplante alogénico de progenitores hematopoyéticos de sangre periférica deplecionado de linfocitos T
Author keywords

[No Author keywords available]
Indexed keywords

CLADRIBINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINBLASTINE;
EID: 33845965322     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095100     Document Type: Letter
Times cited : (5)
References (6)
  • 1
    • 0030767987 scopus 로고    scopus 로고
    • Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society
    • Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997;29:157-66.
    • (1997) Med Pediatr Oncol , vol.29 , pp. 157-166
    • Favara, B.E.1    Feller, A.C.2    Pauli, M.3    Jaffe, E.S.4    Weiss, L.M.5    Arico, M.6
  • 2
    • 0023622859 scopus 로고
    • Evaluating role of therapy in histiocytosis X. Clinical studies, staging and scoring
    • Osband ME, Pochedly C, editors, Philadelphia: W.B. Saunders Company;
    • Lavin PT, Osband ME. Evaluating role of therapy in histiocytosis X. Clinical studies, staging and scoring. En: Osband ME, Pochedly C, editors. Histiocytosis X. Philadelphia: W.B. Saunders Company; 1987. p. 35-47.
    • (1987) Histiocytosis X , pp. 35-47
    • Lavin, P.T.1    Osband, M.E.2
  • 3
    • 10744221069 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for children with histiocytic disorders: Use of TBI and omision of etoposide in the conditioning regimen
    • Hale GA, Bowman LC, Woodard JP, Cunningham JM. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omision of etoposide in the conditioning regimen. Bone Marrow Transplant. 2003;3:981-6.
    • (2003) Bone Marrow Transplant , vol.3 , pp. 981-986
    • Hale, G.A.1    Bowman, L.C.2    Woodard, J.P.3    Cunningham, J.M.4
  • 4
    • 0035690835 scopus 로고    scopus 로고
    • Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation
    • Nagarajan R, Neglia J, Ramsay N, Baker KS. Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. J Pediatr Hematol Oncol. 2001;23:629-32.
    • (2001) J Pediatr Hematol Oncol , vol.23 , pp. 629-632
    • Nagarajan, R.1    Neglia, J.2    Ramsay, N.3    Baker, K.S.4
  • 5
    • 33846022030 scopus 로고    scopus 로고
    • Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
    • Steiner M, Matthes-Martin S, Attarbashi A, Minkov M. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant. 2005;6:1-11.
    • (2005) Bone Marrow Transplant , vol.6 , pp. 1-11
    • Steiner, M.1    Matthes-Martin, S.2    Attarbashi, A.3    Minkov, M.4
  • 6
    • 85030499882 scopus 로고    scopus 로고
    • Treatment Protocol of the Third International Study for Langerhans cell histiocytosis LCH-III, consultado 15/04/2006, Disponible en
    • Treatment Protocol of the Third International Study for Langerhans cell histiocytosis (LCH-III) [consultado 15/04/2006]. Disponible en: http://www.histio.org/society/protocols/trials-protocols.shtml

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.